Milestone Scientific Schedules Second Quarter 2020 Conference Call

Rhea-AI Summary

Milestone Scientific Inc. (MLSS) announced a conference call on August 17, 2020, at 8:30 AM ET, to discuss its financial results for Q2 2020 ending June 30. The call aims to cover corporate progress and developments. Investors can participate via the company's website or by telephone. A replay will be available within an hour after the call until August 31, 2020. Milestone Scientific focuses on innovative drug delivery instruments that enhance injection precision and comfort, utilizing its proprietary Dynamic Pressure Sensing technology.

Positive

• Upcoming conference call to discuss Q2 financial results and corporate progress.
• Focus on innovative drug delivery technology may attract investor interest.

Negative

• None.

LIVINGSTON, NJ / ACCESSWIRE / August 13, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, August 17, 2020 to discuss the Company's financial results for the second quarter ended June 30, 2020, as well as the Company's corporate progress and other developments.

The conference call will be available on the Company's website at www.milestonescientific.com, or via telephone by dialing toll free 877-407-0778 for U.S. callers, or +1 201-689-8565 for international callers. A webcast will also be archived on the Company's website and a telephone replay of the call will be available approximately one hour following the call, through Monday, August 31, 2020, and can be accessed by dialing 877-481-4010 for U.S. callers, or +1 919-882-2331 for international callers and entering the pass code 36611.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.

Contact:

David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

SOURCE: Milestone Scientific, Inc.

View source version on accesswire.com:
https://www.accesswire.com/601466/Milestone-Scientific-Schedules-Second-Quarter-2020-Conference-Call

FAQ

When is Milestone Scientific's Q2 2020 conference call scheduled?

The conference call is scheduled for August 17, 2020, at 8:30 AM ET.

How can I access the Milestone Scientific conference call?

You can access the conference call on Milestone Scientific's website or by dialing 877-407-0778 for U.S. callers.

What will Milestone Scientific discuss in their upcoming conference call?

Milestone Scientific will discuss their financial results for Q2 2020 and corporate progress.

What is Milestone Scientific's stock symbol?

Milestone Scientific's stock symbol is MLSS.

Will there be a replay available for the conference call?

Yes, a replay will be available approximately one hour after the call until August 31, 2020.